{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:13:10Z","timestamp":1759191190274,"version":"3.44.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Tuberculosis (TB) is a recurrent and progressive bacterial disease caused by <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (<jats:italic>Mtb<\/jats:italic>), posing a significant challenge globally due to its drug resistance. This study focuses on identifying natural phytocompounds from the plant <jats:italic>Datura innoxia<\/jats:italic> (leaves), which is well known for its biologically active metabolites. Initially, the current study employed in vitro analysis of 20 phytocompounds, revealing that the natural compound 9, o-vanillin, exhibited the best minimal inhibitory concentration (MIC) which was 12.5\u00a0\u00b5g\/mL, and minimal bactericidal concentration (MBC) was 50 \u00b5g\/mL, all other phytocompounds showing remarkable antitubercular activity against the <jats:italic>Mtb<\/jats:italic> H37Ra strain. The molecular docking and simulation also validated the strong affinity and stable binding interactions between compound 9 and target protein kinase. The pharmacokinetic analysis highlighted the suitable oral bioavailability and no significant CYP450 inhibition for the lead compound 9, reducing the risk for drug-drug interactions. Moreover, the density functional theory analysis of lead compound 9 demonstrated optimal molecular properties, further contributing to the chemical stability and reactivity. Therefore, these results suggest that <jats:italic>D. innoxia<\/jats:italic> contains the potent phytocompound o-vanillin, which possesses antitubercular activity and can potentially be used as a drug against TB. However, future studies will focus on in vivo validation and formulation development for clinical applications.<\/jats:p>","DOI":"10.1038\/s41598-025-99053-1","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:56:37Z","timestamp":1759161397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro investigation of Datura innoxia phytocompounds against Mycobacterium tuberculosis H37Ra strain in association with in silico studies"],"prefix":"10.1038","volume":"15","author":[{"given":"Sajjad Ahmed","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzafar Ahmad","family":"Rather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Umer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Mehmood","family":"Qadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muharib","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony D.","family":"Baughn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Thomas","family":"Shier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Sheeraz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"99053_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s2213-2600(18)30057-2","volume":"6","author":"K Floyd","year":"2018","unstructured":"Floyd, K., Glaziou, P., Zumla, A. & Raviglione, M. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the end TB era. Lancet Respiratory Med. 6, 299\u2013314. https:\/\/doi.org\/10.1016\/s2213-2600(18)30057-2 (2018).","journal-title":"Lancet Respiratory Med."},{"key":"99053_CR2","doi-asserted-by":"crossref","unstructured":"Li, Y. Y., Cai, R. J., Talbot, E. A. & Wang, Y. T. in Molecular Medical Microbiology 1569\u20131584Elsevier, (2024).","DOI":"10.1016\/B978-0-12-818619-0.00010-1"},{"key":"99053_CR3","unstructured":"Geneva Global Tuberculosis Report 2023., (2023)."},{"key":"99053_CR4","unstructured":"Organization, W. H. Global Tuberculosis Report 2018WHO., (2018)."},{"key":"99053_CR5","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1001\/jama.1952.03680100015006","volume":"150","author":"IJ Selikoff","year":"1952","unstructured":"Selikoff, I. J., Robitzek, E. H. & Ornstein, G. G. Treatment of pulmonary tuberculosis with Hydrazide derivatives of Isonicotinic acid. J. Am. Med. Assoc. 150, 973\u2013980. https:\/\/doi.org\/10.1001\/jama.1952.03680100015006 (1952).","journal-title":"J. Am. Med. Assoc."},{"key":"99053_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1056\/nejm196903132801112","volume":"280","author":"TM Daniel","year":"1969","unstructured":"Daniel, T. M. Rifampin\u2013a major new chemotherapeutic agent for the treatment of tuberculosis. N. Engl. J. Med. 280, 615\u2013616. https:\/\/doi.org\/10.1056\/nejm196903132801112 (1969).","journal-title":"N. Engl. J. Med."},{"key":"99053_CR7","doi-asserted-by":"publisher","first-page":"8800","DOI":"10.3390\/molecules20058800","volume":"20","author":"WM Eldehna","year":"2015","unstructured":"Eldehna, W. M., Fares, M., Abdel-Aziz, M. M. & Abdel-Aziz, H. A. Design, synthesis and antitubercular activity of certain nicotinic acid Hydrazides. Molecules (Basel Switzerland). 20, 8800\u20138815. https:\/\/doi.org\/10.3390\/molecules20058800 (2015).","journal-title":"Molecules (Basel Switzerland)"},{"key":"99053_CR8","doi-asserted-by":"publisher","first-page":"11275","DOI":"10.1038\/s41598-023-38394-1","volume":"13","author":"HJ Kim","year":"2023","unstructured":"Kim, H. J. et al. Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis. Sci. Rep. 13, 11275. https:\/\/doi.org\/10.1038\/s41598-023-38394-1 (2023).","journal-title":"Sci. Rep."},{"key":"99053_CR9","doi-asserted-by":"publisher","unstructured":"Bunalema, L., Fotso, G. W., Waako, P., Tabuti, J. & Yeboah, S. O. Potential of Zanthoxylum leprieurii as a source of active compounds against drug resistant Mycobacterium tuberculosis. BMC Complement. Altern. Med. 17 https:\/\/doi.org\/10.1186\/s12906-017-1602-x (2017).","DOI":"10.1186\/s12906-017-1602-x"},{"key":"99053_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/1389557516666160505114603","volume":"17","author":"D Sharma","year":"2017","unstructured":"Sharma, D. & Yadav, J. P. An overview of phytotherapeutic approaches for the treatment of tuberculosis. Mini Rev. Med. Chem. 17, 167\u2013183. https:\/\/doi.org\/10.2174\/1389557516666160505114603 (2017).","journal-title":"Mini Rev. Med. Chem."},{"key":"99053_CR11","doi-asserted-by":"publisher","unstructured":"Bahuguna, A. & Rawat, D. S. An overview of new antitubercular drugs, drug candidates, and their targets. 40, 263\u2013292, (2020). https:\/\/doi.org\/10.1002\/med.21602","DOI":"10.1002\/med.21602"},{"key":"99053_CR12","doi-asserted-by":"publisher","unstructured":"Khadka, D. et al. The use of medicinal plants to prevent COVID-19 in Nepal. 17, 26, (2021). https:\/\/doi.org\/10.1186\/s13002-021-00449-w","DOI":"10.1186\/s13002-021-00449-w"},{"issue":"Suppl 1","key":"99053_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1289\/ehp.01109s169","volume":"109","author":"DS Fabricant","year":"2001","unstructured":"Fabricant, D. S. & Farnsworth, N. R. The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect. 109 (Suppl 1), 69\u201375. https:\/\/doi.org\/10.1289\/ehp.01109s169 (2001).","journal-title":"Environ. Health Perspect."},{"key":"99053_CR14","doi-asserted-by":"publisher","unstructured":"Atanasov, A. G., Zotchev, S. B. & Dirsch, V. M. Natural products in drug discovery: advances and opportunities. 20, 200\u2013216, (2021). https:\/\/doi.org\/10.1038\/s41573-020-00114-z","DOI":"10.1038\/s41573-020-00114-z"},{"key":"99053_CR15","unstructured":"KARDI, C. & SEKIOU, S. Valorisation D\u2019une Plante Poussant Spontan\u00e9ment Dans La R\u00e9gion De Tipaza (Alg\u00e9rie), Par L\u2019analyse Phytochimique Et L\u2019\u00e9tude Des Activit\u00e9s Biologiques De Ses Extraits (Universite laarbi tebessi tebessa, 2020)."},{"key":"99053_CR16","doi-asserted-by":"publisher","unstructured":"Chopra, B. & Dhingra, A. K. Natural products: A lead for drug discovery and development. 35, 4660\u20134702, (2021). https:\/\/doi.org\/10.1002\/ptr.7099","DOI":"10.1002\/ptr.7099"},{"key":"99053_CR17","doi-asserted-by":"publisher","unstructured":"Sharma, M., Dhaliwal, I., Rana, K. & Phytochemistry Pharmacology, and toxicology of Datura Species-A review. 10, (2021). https:\/\/doi.org\/10.3390\/antiox10081291","DOI":"10.3390\/antiox10081291"},{"key":"99053_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3736\/jintegrmed2013016","volume":"11","author":"BP Gaire","year":"2013","unstructured":"Gaire, B. P. & Subedi, L. A review on the Pharmacological and toxicological aspects of Datura stramonium L. J. Integr. Med. 11, 73\u201379. https:\/\/doi.org\/10.3736\/jintegrmed2013016 (2013).","journal-title":"J. Integr. Med."},{"key":"99053_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13568-024-01741-0","volume":"14","author":"S Islam","year":"2024","unstructured":"Islam, S. et al. Antibacterial potential of propolis: molecular docking, simulation and toxicity analysis. AMB Express. 14, 81. https:\/\/doi.org\/10.1186\/s13568-024-01741-0 (2024).","journal-title":"AMB Express"},{"key":"99053_CR20","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.2174\/1381612826666200519113752","volume":"27","author":"W Alam","year":"2021","unstructured":"Alam, W., Khan, H., Khan, S. A., Nazir, S. & Akkol, E. K. Datura Metel: A review on chemical constituents, traditional uses and Pharmacological activities. Curr. Pharm. Design. 27, 2545\u20132557. https:\/\/doi.org\/10.2174\/1381612826666200519113752 (2021).","journal-title":"Curr. Pharm. Design"},{"key":"99053_CR21","doi-asserted-by":"publisher","unstructured":"Maddeboina, K. et al. Recent advances in multitarget-directed ligands via in Silico drug discovery. Drug Discovery Today. 29 https:\/\/doi.org\/10.1016\/j.drudis.2024.103904 (2024).","DOI":"10.1016\/j.drudis.2024.103904"},{"key":"99053_CR22","doi-asserted-by":"publisher","unstructured":"da Fonseca, A. M. & Caluaco, B. J. Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking, and approach with molecular dynamics, RMSD, RMSF, H-Bond, SASA and MMGBSA. 66, 1919\u20131933, (2024). https:\/\/doi.org\/10.1007\/s12033-023-00831-x","DOI":"10.1007\/s12033-023-00831-x"},{"key":"99053_CR23","doi-asserted-by":"publisher","unstructured":"Elkaeed, E. B., Yousef, R. G. & Design, Synthesis, Docking, D. F. T. MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects. 27, (2022). https:\/\/doi.org\/10.3390\/molecules27144606","DOI":"10.3390\/molecules27144606"},{"key":"99053_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/10406638.2023.2173618","volume":"44","author":"FM Ahamed","year":"2024","unstructured":"Ahamed, F. M. et al. Molecular dynamics simulation, QSAR, DFT, molecular docking, ADMET, and synthesis of Ethyl 3-((5-Bromopyridin-2-yl) Imino) butanoate analogues as potential inhibitors of SARS-CoV-2. Polycycl. Aromat. Compd. 44, 294\u2013312 (2024).","journal-title":"Polycycl. Aromat. Compd."},{"key":"99053_CR25","doi-asserted-by":"publisher","first-page":"104465","DOI":"10.1016\/j.bioorg.2020.104465","volume":"106","author":"G Mallikarjuna Reddy","year":"2021","unstructured":"Mallikarjuna Reddy, G., Camilo, A. Jr. & Raul Garcia, J. Pyrrole-2,5-dione analogs as a promising antioxidant agents: microwave-assisted synthesis, bio-evaluation, SAR analysis and DFT studies\/interpretation. Bioorg. Chem. 106, 104465. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104465 (2021).","journal-title":"Bioorg. Chem."},{"key":"99053_CR26","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1038\/s41598-023-31499-7","volume":"13","author":"SA Ejaz","year":"2023","unstructured":"Ejaz, S. A., Aziz, M., Zafar, Z., Akhtar, N. & Ogaly, H. A. Revisiting the inhibitory potential of protein kinase inhibitors against NEK7 protein via comprehensive computational investigations. Sci. Rep. 13, 4304. https:\/\/doi.org\/10.1038\/s41598-023-31499-7 (2023).","journal-title":"Sci. Rep."},{"key":"99053_CR27","doi-asserted-by":"publisher","unstructured":"Rahman, J., Tareq, A. M. & Biological Evaluation, D. F. T. Calculations and molecular Docking studies on the antidepressant and cytotoxicity activities of Cycas pectinata Buch.-Ham. Compounds 13 https:\/\/doi.org\/10.3390\/ph13090232 (2020).","DOI":"10.3390\/ph13090232"},{"key":"99053_CR28","first-page":"203","volume":"15","author":"SM Kawsar","year":"2022","unstructured":"Kawsar, S. M. et al. Chemical descriptors, PASS, molecular docking, molecular dynamics and ADMET predictions of glucopyranoside derivatives as inhibitors to bacteria and fungi growth. Org. Commun. 15, 203 (2022).","journal-title":"Org. Commun."},{"key":"99053_CR29","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","volume":"59","author":"M De Vivo","year":"2016","unstructured":"De Vivo, M., Masetti, M., Bottegoni, G. & Cavalli, A. Role of molecular dynamics and related methods in drug discovery. J. Med. Chem. 59, 4035\u20134061. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01684 (2016).","journal-title":"J. Med. Chem."},{"key":"99053_CR30","doi-asserted-by":"publisher","first-page":"117863612311524","DOI":"10.1177\/11786361231152438","volume":"16","author":"P Yadav","year":"2023","unstructured":"Yadav, P. & Challenges Solutions for recent advancements in Multi-Drugs resistance tuberculosis: A review. Microbiol. Insights. 16, 11786361231152438. https:\/\/doi.org\/10.1177\/11786361231152438 (2023).","journal-title":"Microbiol. Insights"},{"key":"99053_CR31","doi-asserted-by":"publisher","unstructured":"Khan, M. U. et al. Identification of novel natural compounds against CFTR p.Gly628Arg pathogenic variant. 14, 99, (2024). https:\/\/doi.org\/10.1186\/s13568-024-01762-9","DOI":"10.1186\/s13568-024-01762-9"},{"key":"99053_CR32","doi-asserted-by":"publisher","unstructured":"Sakhawat, A. et al. Natural compound targeting BDNF V66M variant: insights from in Silico Docking and molecular analysis. 13, 134, (2023). https:\/\/doi.org\/10.1186\/s13568-023-01640-w","DOI":"10.1186\/s13568-023-01640-w"},{"key":"99053_CR33","doi-asserted-by":"publisher","unstructured":"Ur Rahman, M., Khan, M., Khan, S. W. & Khan, R. U. Novel schiff bases of Vanillin: potent inhibitors of macrophage harbored leishmania tropica. 47, 619\u2013629, (2023). https:\/\/doi.org\/10.1007\/s12639-023-01594-7","DOI":"10.1007\/s12639-023-01594-7"},{"key":"99053_CR34","doi-asserted-by":"publisher","first-page":"e0232482","DOI":"10.1371\/journal.pone.0232482","volume":"15","author":"R Ravindran","year":"2020","unstructured":"Ravindran, R., Chakrapani, G., Mitra, K. & Doble, M. Inhibitory activity of traditional plants against Mycobacterium smegmatis and their action on filamenting temperature sensitive mutant Z (FtsZ)-A cell division protein. PloS One. 15, e0232482. https:\/\/doi.org\/10.1371\/journal.pone.0232482 (2020).","journal-title":"PloS One"},{"key":"99053_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.29252\/.22.6.401","volume":"22","author":"N Rahgozar","year":"2018","unstructured":"Rahgozar, N., Khaniki, B., Sardari, S. & G. & Evaluation of antimycobacterial and synergistic activity of plants selected based on cheminformatic parameters. Iran. Biomed. J. 22, 401\u2013407. https:\/\/doi.org\/10.29252\/.22.6.401 (2018).","journal-title":"Iran. Biomed. J."},{"key":"99053_CR36","doi-asserted-by":"publisher","unstructured":"Thongdee, P. & Hanwarinroj, C. Virtual screening identifies novel and potent inhibitors of Mycobacterium tuberculosis PknB with antibacterial activity. 62, 6508\u20136518, (2022). https:\/\/doi.org\/10.1021\/acs.jcim.2c00531","DOI":"10.1021\/acs.jcim.2c00531"},{"key":"99053_CR37","doi-asserted-by":"publisher","unstructured":"Vieira, T. F. & Martins, F. G. In Silico Identification of Possible Inhibitors for Protein Kinase B (PknB) of Mycobacterium tuberculosis. 26, (2021). https:\/\/doi.org\/10.3390\/molecules26206162","DOI":"10.3390\/molecules26206162"},{"key":"99053_CR38","doi-asserted-by":"publisher","first-page":"107991","DOI":"10.1016\/j.compbiolchem.2023.107991","volume":"108","author":"M Jayaraman","year":"2024","unstructured":"Jayaraman, M., Gosu, V., Kumar, R. & Jeyaraman, J. Computational insights into potential marine natural products as selective inhibitors of Mycobacterium tuberculosis InhA: A structure-based virtual screening study. Comput. Biol. Chem. 108, 107991. https:\/\/doi.org\/10.1016\/j.compbiolchem.2023.107991 (2024).","journal-title":"Comput. Biol. Chem."},{"key":"99053_CR39","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jtumed.2024.06.008","volume":"19","author":"A Sakhawat","year":"2024","unstructured":"Sakhawat, A. et al. In Silico and in vitro analyses to investigate the effects of vitamin C on VEGF protein. J. Taibah Univ. Med. Sci. 19, 775\u2013789. https:\/\/doi.org\/10.1016\/j.jtumed.2024.06.008 (2024).","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"99053_CR40","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.1038\/s41598-024-57124-9","volume":"14","author":"K Nyambo","year":"2024","unstructured":"Nyambo, K. et al. Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria. Sci. Rep. 14, 6794. https:\/\/doi.org\/10.1038\/s41598-024-57124-9 (2024).","journal-title":"Sci. Rep."},{"key":"99053_CR41","first-page":"901","volume":"9","author":"A Martin","year":"2005","unstructured":"Martin, A. et al. Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. Int. J. Tuberculosis Lung Disease: Official J. Int. Union against Tuberculosis Lung Disease. 9, 901\u2013906 (2005).","journal-title":"Int. J. Tuberculosis Lung Disease: Official J. Int. Union against Tuberculosis Lung Disease"},{"key":"99053_CR42","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1128\/aac.00266-11","volume":"55","author":"C Vilch\u00e8ze","year":"2011","unstructured":"Vilch\u00e8ze, C. et al. Novel inhibitors of InhA efficiently kill Mycobacterium tuberculosis under aerobic and anaerobic conditions. Antimicrob. Agents Chemother. 55, 3889\u20133898. https:\/\/doi.org\/10.1128\/aac.00266-11 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"99053_CR43","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1021\/acsmedchemlett.7b00239","volume":"8","author":"T Wang","year":"2017","unstructured":"Wang, T. et al. Mtb PKNA\/PKNB dual Inhibition provides selectivity advantages for inhibitor design to minimize host kinase interactions. ACS Med. Chem. Lett. 8, 1224\u20131229. https:\/\/doi.org\/10.1021\/acsmedchemlett.7b00239 (2017).","journal-title":"ACS Med. Chem. Lett."},{"key":"99053_CR44","doi-asserted-by":"publisher","unstructured":"Mishra, A., Mulpuru, V. & Mishra, N. An interaction network driven approach for identifying cervical, endometrial, vulvar carcinomic biomarkers and their Multi-targeted inhibitory agents from few widely available medicinal plants. 195, 6893\u20136912, (2023). https:\/\/doi.org\/10.1007\/s12010-023-04441-w","DOI":"10.1007\/s12010-023-04441-w"},{"key":"99053_CR45","doi-asserted-by":"publisher","unstructured":"Modanwal, S., Mishra, A. & Mishra, N. An integrative analysis of GEO data to identify possible therapeutic biomarkers of prostate cancer and targeting potential protein through Zea mays phytochemicals by virtual screening approaches. J. Biomol. Struct. Dyn. 1\u201321. https:\/\/doi.org\/10.1080\/07391102.2023.2283163 (2023).","DOI":"10.1080\/07391102.2023.2283163"},{"key":"99053_CR46","doi-asserted-by":"publisher","unstructured":"Rajput, D., Jain, D., Kashaw, S. K. & Patil, U. K. Molecular Docking studies on phytoconstituent isolated from Nyctanthes arbortristis Linn. Int. J. Pharm. Invest. 14, 399\u2013408. https:\/\/doi.org\/10.5530\/ijpi.14.2.50 (2024).","DOI":"10.5530\/ijpi.14.2.50"},{"key":"99053_CR47","doi-asserted-by":"publisher","unstructured":"Seeliger, D. & de Groot, B. L. Conformational transitions upon ligand binding: holo-structure prediction from apo conformations. PLoS computational biology 6, e1000634, (2010). https:\/\/doi.org\/10.1371\/journal.pcbi.1000634","DOI":"10.1371\/journal.pcbi.1000634"},{"key":"99053_CR48","doi-asserted-by":"publisher","first-page":"107876","DOI":"10.1016\/j.jmgm.2021.107876","volume":"105","author":"S Ikram","year":"2021","unstructured":"Ikram, S., Ahmad, F., Ahmad, J. & Durdagi, S. Screening of small molecule libraries using combined text mining, ligand- and target-driven based approaches for identification of novel granzyme H inhibitors. J. Mol. Graph. Model. 105, 107876. https:\/\/doi.org\/10.1016\/j.jmgm.2021.107876 (2021).","journal-title":"J. Mol. Graph. Model."},{"key":"99053_CR49","doi-asserted-by":"publisher","first-page":"10904","DOI":"10.1038\/s41598-024-61752-6","volume":"14","author":"MF Khan","year":"2024","unstructured":"Khan, M. F. et al. Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis. Sci. Rep. 14, 10904. https:\/\/doi.org\/10.1038\/s41598-024-61752-6 (2024).","journal-title":"Sci. Rep."},{"key":"99053_CR50","doi-asserted-by":"publisher","unstructured":"Rehman, H. M. & Sajjad, M. Identification of NS2B-NS3 protease inhibitors for therapeutic application in ZIKV infection: A Pharmacophore-Based High-Throughput virtual screening and MD simulations approaches. 11, (2023). https:\/\/doi.org\/10.3390\/vaccines11010131","DOI":"10.3390\/vaccines11010131"},{"key":"99053_CR51","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","volume":"29","author":"S Pronk","year":"2013","unstructured":"Pronk, S. et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinf. (Oxford England). 29, 845\u2013854. https:\/\/doi.org\/10.1093\/bioinformatics\/btt055 (2013).","journal-title":"Bioinf. (Oxford England)"},{"key":"99053_CR52","doi-asserted-by":"publisher","first-page":"106978","DOI":"10.1016\/j.compbiomed.2023.106978","volume":"160","author":"V Gosu","year":"2023","unstructured":"Gosu, V. et al. Deciphering the intrinsic dynamics of unphosphorylated IRAK4 kinase bound to type I and type II inhibitors. Comput. Biol. Med. 160, 106978. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106978 (2023).","journal-title":"Comput. Biol. Med."},{"key":"99053_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2116\/analsci.19R006","volume":"36","author":"S Morita","year":"2020","unstructured":"Morita, S. Chemometrics and related fields in Python. Anal. Sciences: Int. J. Japan Soc. Anal. Chem. 36, 107\u2013111. https:\/\/doi.org\/10.2116\/analsci.19R006 (2020).","journal-title":"Anal. Sciences: Int. J. Japan Soc. Anal. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99053-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99053-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99053-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:56:39Z","timestamp":1759161399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99053-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99053"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99053-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"3 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33454"}}